vs
Side-by-side financial comparison of Autohome Inc. (ATHM) and BIOCRYST PHARMACEUTICALS INC (BCRX). Click either name above to swap in a different company.
Autohome Inc. is the larger business by last-quarter revenue ($249.8M vs $156.4M, roughly 1.6× BIOCRYST PHARMACEUTICALS INC). Over the past eight quarters, BIOCRYST PHARMACEUTICALS INC's revenue compounded faster (19.6% CAGR vs -0.6%).
Autohome Inc. is a leading online destination for automobile consumers in China. Through its websites and mobile apps, it provides professionally produced content, user-generated content, comprehensive vehicle listings, and a suite of services for dealers, automakers, and car buyers, including new and used car listings, financing, insurance, and online transactions.
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.
ATHM vs BCRX — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $249.8M | $156.4M |
| Net Profit | $59.4M | — |
| Gross Margin | 63.7% | — |
| Operating Margin | 8.3% | 13.6% |
| Net Margin | 23.8% | — |
| Revenue YoY | — | 7.5% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $156.4M | ||
| Q4 25 | — | $406.6M | ||
| Q3 25 | $249.8M | $159.4M | ||
| Q2 25 | $245.4M | $163.4M | ||
| Q1 25 | $244.3M | $145.5M | ||
| Q4 24 | — | $131.5M | ||
| Q3 24 | $252.9M | $117.1M | ||
| Q2 24 | $257.7M | $109.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $245.8M | ||
| Q3 25 | $59.4M | $12.9M | ||
| Q2 25 | $56.0M | $5.1M | ||
| Q1 25 | — | $32.0K | ||
| Q4 24 | — | $-26.8M | ||
| Q3 24 | $61.0M | $-14.0M | ||
| Q2 24 | $69.3M | $-12.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 97.7% | ||
| Q3 25 | 63.7% | 98.6% | ||
| Q2 25 | 71.4% | 98.3% | ||
| Q1 25 | — | 96.9% | ||
| Q4 24 | — | 95.4% | ||
| Q3 24 | 77.0% | 97.3% | ||
| Q2 24 | 81.5% | 98.4% |
| Q1 26 | — | 13.6% | ||
| Q4 25 | — | 64.0% | ||
| Q3 25 | 8.3% | 18.6% | ||
| Q2 25 | 16.9% | 18.2% | ||
| Q1 25 | 13.0% | 14.6% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | 4.7% | 6.6% | ||
| Q2 24 | 22.0% | 8.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 60.5% | ||
| Q3 25 | 23.8% | 8.1% | ||
| Q2 25 | 22.8% | 3.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | -20.4% | ||
| Q3 24 | 24.1% | -12.0% | ||
| Q2 24 | 26.9% | -11.6% |
| Q1 26 | — | $0.00 | ||
| Q4 25 | — | $1.13 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $259.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | — | $465.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $259.0M | ||
| Q4 25 | — | $274.7M | ||
| Q3 25 | — | $212.9M | ||
| Q2 25 | — | $260.0M | ||
| Q1 25 | — | $295.1M | ||
| Q4 24 | — | $320.9M | ||
| Q3 24 | — | $96.8M | ||
| Q2 24 | — | $78.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-119.2M | ||
| Q3 25 | — | $-387.9M | ||
| Q2 25 | — | $-421.6M | ||
| Q1 25 | — | $-451.9M | ||
| Q4 24 | — | $-475.9M | ||
| Q3 24 | — | $-468.6M | ||
| Q2 24 | — | $-475.6M |
| Q1 26 | — | $465.1M | ||
| Q4 25 | — | $514.2M | ||
| Q3 25 | — | $446.4M | ||
| Q2 25 | — | $457.2M | ||
| Q1 25 | — | $480.0M | ||
| Q4 24 | — | $490.4M | ||
| Q3 24 | — | $491.3M | ||
| Q2 24 | — | $472.4M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATHM
| Online marketplace and others | $114.7M | 46% |
| Leads generation services | $93.2M | 37% |
| Media services | $41.9M | 17% |
BCRX
| ORLADEYO | $148.3M | 95% |
| Other revenues | $5.0M | 3% |
| License revenue | $3.0M | 2% |
